Search results
Results from the WOW.Com Content Network
Pages in category "Drugs developed by Johnson & Johnson" The following 146 pages are in this category, out of 146 total. This list may not reflect recent changes. A.
Carbonate derivatives of 14β-hydroxycodeine "viz., 14β-hydroxy-6-O-(methoxycarbonyl)codeine, 6-O-methoxycarbonyl-14β-(methoxycarbonyloxy)codeine, and 14β-acetoxy-6-O-methoxy-carbonylcodeine, potential substrates for ring C modification in morphinane (sic) alkaloids, were synthesized for the first time."
This page was last edited on 11 December 2024, at 07:02 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
Drug Main indication Trade name 2015 2016 ... Johnson & Johnson: 8,355 1,487 5 Rituximab: Mabthera Rituxan ... opioid addiction: Aug-2000: Mon-20XX 40: Viagra:
Johnson & Johnson has a global workforce of approximately 130,000 employees who are led by the company's current chairman and chief executive officer, Joaquin Duato. Johnson & Johnson was founded in 1886 by three brothers, Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson, selling ready
Johnson & Johnson's pharmaceuticals branch is more than just immunology, however -- and other drugs bring in more and more rivals to watch. Remicade might be safe from patent expiration, but some ...
Three major drug distributors and drugmaker Johnson & Johnson agreed to finalize a $26 billion opioid crisis settlement with more than 40 states and thousands of local governments Friday.
The structure-activity relationship of the drug class has been explored to a reasonable extent. The optimal substitution pattern is fairly tightly defined (i.e. N,N-diethyl on the amine nitrogen, 4-ethoxy on the benzyl ring and 5-nitro on the benzimidazole ring), but even derivatives incorporating only some of these features are still potent opioids.